COBRA-OS® Ordering Information for Military – Please click here.
Aortic Occlusion, Valve Procedures, Transcatheter Valve, Vascular Access Complications

Using COBRA-OS® for Aortic Occlusion in Transcatheter Valve Complications

Vascular Access Complications in Transcatheter Valve Procedures

Transcatheter valve interventions, especially transfemoral transcatheter aortic valve replacement (TAVR), have revolutionized cardiac care for aortic stenosis. However, large-bore arterial access is required (often via the femoral and iliac arteries), and this comes with a risk of vascular complications[1][2]. Despite advances (smaller delivery sheaths and improved techniques), iliac or femoral artery injuries remain serious albeit less frequent events. Published series report iliac artery dissection in 1.6 to 21.4% of TAVR cases (depending on technique), and potentially fatal iliac artery rupture in about 0.7% up to 9.3% of TAVR procedures (with lower rates in recent years due to low-profile systems)[3]. Although rare, a rupture of a femoral or iliac artery during TAVR is a life-threatening emergency; patients can deteriorate rapidly from massive hemorrhage[4]. In fact, sudden hemodynamic collapse in the cath lab after valve deployment often raises concern for an arterial access rupture among the differential diagnoses[5][6].

The clinical impact of such complications is devastating if not managed immediately. Even when incidence is low, mortality can be high for major arterial injuries like aortic or iliac dissections/ruptures[7]. Therefore, TAVR heart teams place heavy emphasis on preventing and preparing for vascular complications[1]. Pre-procedural planning (CT sizing, assessing vessel caliber and calcification) helps minimize risk, and newer generation valves use smaller sheaths to reduce trauma[8]. Yet, in frail patients with diffuse atherosclerosis or small, calcified iliac arteries, arterial rupture can still occur ; for example, upon withdrawing a large sheath from a heavily calcified iliac, leading to arterial avulsion[9]. In these dire scenarios, time is critical. Rapid control of bleeding is required to prevent exsanguination long enough to definitively repair the artery[10].

Emergency Management of Iliac Artery Rupture During TAVR

Managing an iliac artery rupture during a transcatheter valve procedure demands an immediate, coordinated response. The goal is to temporize the hemorrhage and stabilize the patient’s hemodynamics while a permanent fix is arranged. Traditional open surgical conversion (emergency vascular surgery) is an option, but in many cases it may be too slow; a severe iliac rupture can cause rapid retroperitoneal bleeding where even a few minutes of delay is catastrophic[11]. Instead, endovascular rescue techniques are the first-line approach in modern TAVR suites.

The recommended emergency steps typically include:

1. Aortic Balloon Occlusion: As soon as an iliac rupture is suspected (e.g. sudden hypotension after sheath removal), a large occlusion balloon is deployed in the

aorta to halt distal blood flow. In practice, this is often done by quickly accessing the contralateral femoral artery (if the rupture occurred on the right, use the left, or vice versa) and advancing a balloon catheter to the aortic bifurcation. Inflating the balloon in the distal abdominal aorta stanches bleeding to the pelvis/leg and buys time for resuscitation[10]. Clinical case reports have demonstrated the efficacy of this: for example, one TAVR case of iliac rupture was stabilized by promptly inflating a 30 mm balloon in the aorta, which blocked further blood loss and restored blood pressure[6]. Contemporary reviews likewise advise that immediate balloon occlusion of the descending or abdominal aorta should be performed to control hemorrhage from an arterial injury, followed by definitive repair[12][13].

2. Reversal of Anticoagulation: TAVR patients are typically heparinized. After balloon occlusion, reversing anticoagulation (e.g. protamine) can help reduce ongoing bleeding[14]. Minor vascular tears might even seal with just balloon tamponade and heparin reversal[13].

3. Definitive Repair: Covered Stent or Surgery: With the aortic balloon controlling hemorrhage, the team can visualize the injury via angiography and then fix it. Often, the solution is to deploy a covered stent graft across the iliac artery tear (if anatomy allows)[15]. In the TAVR lab setting, having assorted covered stents on hand is crucial for this very reason[16]. In the earlier case example, once the balloon was up, a wire was passed across the iliac lesion and a 10×80 mm covered stent was placed, successfully sealing the rupture and immediately restoring hemodynamic stability[17]. Alternatively, if endovascular stenting fails or is not feasible, urgent surgical repair (open patch or graft interposition) is the backup ; though surgery after TAVR is often a last resort due to the high risk and time delay[11].

By following the above steps, many catastrophic access-site injuries can be managed in the cath lab itself. Notably, experts emphasize that preparedness is key: the team should have occlusion balloons and covered stents available during TAVR in case of rupture[10]. Prompt aortic occlusion is the cornerstone to avoid loss of the patient on the table while the arterial tear is addressed. This concept, temporarily controlling inflow to stop bleeding, is essentially an application of REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) in the structural heart context.

COBRA-OS®: A Low-Profile Aortic Occlusion Device for Emergencies

Entering the scene is the COBRA-OS® (Control Of Bleeding, Resuscitation, Arterial Occlusion System), a novel REBOA catheter developed by Front Line Medical Technologies. The COBRA-OS® is gaining attention as a particularly useful tool for scenarios like TAVR access complications. What sets it apart from traditional aortic occlusion balloons is its ultra-low profile design. The COBRA-OS® is the world’s first 4 French REBOA device, meaning it only requires a tiny 4 Fr arterial sheath for insertion[18].

This is dramatically smaller than conventional REBOA catheters (which are typically 7-12 Fr). The device was specifically engineered to minimize access trauma and simplify deployment, without sacrificing efficacy in occluding the aorta[19].

Why is a 4 Fr profile so valuable in a TAVR complication? In the midst of a rupture, the contralateral femoral artery is your lifeline for delivering a balloon. That artery might itself be small or diseased in an elderly TAVR patient. Using a large 7-8 Fr sheath on the remaining access could be challenging or could even cause a secondary injury. COBRA-OS®’s 4 Fr sheath (approximately 1.3 mm in diameter) virtually guarantees you can get an occlusion balloon in place on the opposite side, even in narrow or calcified arteries[20]. The low-profile also means fewer procedural steps and easier insertion; no surgical cutdown is needed and arterial closure is simpler afterward[21][19]. In fact, the device’s design was intended to decrease procedure time and reduce access site complications compared to larger REBOA systems[19]. These factors are crucial when working under extreme time pressure.

From a practical standpoint, COBRA-OS® comes as an all-in-one kit with a 0.018” guidewire, the 4 Fr sheath, and a custom inflation syringe, making it straightforward for the team to grab and deploy in an emergency[25]. Dr. Adam Power, a vascular surgeon and co-founder of the company, noted that the simplicity of the system means “when a patient is bleeding to death in front of you, simple solutions are key,” and COBRA-OS® is designed to be the “most straightforward REBOA device” available[26].

Speed Is Life: Rapid Aortic Occlusion with COBRA-OS®

In a rupture scenario, speed of aortic occlusion is everything. Every minute of ongoing hemorrhage increases the risk of cardiac arrest or irreversible shock. One of the most impressive aspects of the COBRA-OS® is the speed at which it can be deployed. Studies have shown that while typical REBOA catheter placement can take 5-10 minutes (or longer in inexperienced hands), the COBRA-OS® can be positioned and inflated in just about one minute on average[27]. This drastic reduction in deployment time, on the order of several minutes saved, can truly make the difference between life and death in an acute bleed. The device’s 4 Fr size contributes to this speed; because it’s so small and flexible, it can be inserted quickly and navigated up to the aorta with minimal resistance[28][27]. Fewer steps are involved (no need for upsizing dilators or large arterial closures, etc.), which streamlines the procedure in critical moments[21].

To put it plainly, COBRA-OS® enables rapid aortic control. In the context of a TAVR iliac rupture, this means the balloon could be up and occluding the aorta within a minute or two of recognizing the complication. By quickly stopping the hemorrhage, the heart team can then work on definitive repair under much more stable conditions. The device essentially serves as an endovascular “safety net”; a bridge to keep the patient alive and perfusing their vital organs while the bleeding vessel is fixed. Front Line Medical’s experience in trauma resuscitation has shown that controlling bleeding “in fewer steps and less invasively” can decrease complication rates and improve outcomes[29]. Those same

principles apply in the cath lab. Speedy occlusion can abbreviate the duration of hypotension, reducing the risk of cardiac arrest or neurologic injury during the event.

Conclusion

Access site complications in transcatheter valve procedures are uncommon but critical events. When an iliac artery is ruptured during a TAVR, having the ability to immediately occlude the aorta can be lifesaving. The COBRA-OS® device offers a new level of preparedness for such emergencies: its ultra low-profile design, ease of use, and rapid deployment dramatically improve our ability to perform REBOA in the cath lab setting. By temporarily blocking the aorta, COBRA-OS® keeps the patient alive and buys precious minutes for the team to stanch the bleeding definitively (for example, by deploying a covered stent in the injured iliac)[10][13]. The latest literature and case experience underscore that time and simplicity are paramount in hemorrhage control; and in these regards, COBRA-OS® is a game-changer.

Sources:

· Franke J. et al. “Managing Iliac Rupture After TAVI ; Case Study.” Cardiac Interventions Today. 2011.[10][17]

· Simon P. & Andreas M. “Vascular Complications in TAVR: Incidence, Clinical Impact, and Management.” J. Clin. Med. 2021;10(21):5046.[3][13]

· Front Line Medical Technologies. Product information ; COBRA-OS®® (accessed 2025)[21][19]

· Front Line Medical Tech Press Release (Adam Power, MD quote), via Vascular News. Jul 2021.[28] · Front Line Medical Tech News Release, Endovascular Today. Feb 2022.[19][26] · Vascular News. “FDA clears COBRA-OS®…”. Jul 2021.[27][18]

[1] [2] [3] [4] [7] [8] [9] [12] [13] [14] Vascular Complications in TAVR: Incidence, Clinical Impact, and Management

https://www.mdpi.com/2077-0383/10/21/5046

[5] [6] [10] [11] [15] [16] [17] Managing Iliac Rupture After TAVI – Cardiac Interventions Today

https://citoday.com/articles/2011-may-june/managing-iliac-rupture-after-tavi [18] [20] [23] [27] [28] [29] FDA clears Front Line Medical Technologies’ COBRA-OS® bleeding control device

https://vascularnews.com/fda-clears-front-line-medical-technologies-COBRA-OS®-bleeding-control-device/

[19] [26] Front Line Medical’s COBRA-OS® Aortic Occlusion Device Available in United States and Canada – Endovascular Today

https://evtoday.com/news/front-line-medicals-COBRA-OS®-aortic-occlusion-device-available-in-united-states-and-canada [21] [22] [24] [25] COBRA-OS® – Front Line Medical Technologies

https://frontlinemedtech.com/COBRA-OS®

 

Share:

Facebook
Twitter
LinkedIn
On Key

Related Posts

Clinician performing an endovascular procedure during prolonged partial REBOA, with patient monitoring and an elapsed-time clock visible.

Before We Extend the Clock: A Cautious Look at Prolonged Partial REBOA

Partial REBOA may offer advantages over complete aortic occlusion, but extending occlusion time raises important questions about patient selection, transport, monitoring and delays to definitive hemorrhage control. This article examines why stronger human evidence is needed before prolonged partial REBOA becomes routine practice.

Doctor meeting with a medical technology developer discussing AI-powered MedTech innovation beside a digital interface displaying robotic surgical technology.

Speed Is Not Wisdom: MedTech Innovation in the Age of AI

Aortic occlusion has traditionally been viewed as a rescue intervention for severe hemorrhage. New evidence suggests low-profile systems may support a broader role, helping clinicians proactively manage predictable bleeding in selected surgical and trauma cases.